New drug could help SLOW AGING

Basic Applied Science
14 followers
5 Video Views·Sep 25, 2026
Several new drugs are being investigated to slow the aging process by targeting mechanisms such as chronic inflammation, cellular damage, and metabolism. However, most remain in the testing phase and have not yet been proven safe and effective for widespread human use.
AI Generated·May contain errors
Video Summary
AI GeneratedAn AI-generated drug called Rintasirib, developed by Insilico, shows potential in treating idiopathic pulmonary fibrosis while simultaneously slowing the biological aging process. By blocking the TNIK protein to prevent scarring and inflammation, the drug helps the body remove aged cells, potentially reducing the risk of age-related diseases.
Had a potential breakthrough in the fight against aging.
Early data suggesting that an AI-generated drug
might just treat a rare lung disease
and also slow down the biological clock along the way.
This is intriguing.
Fox News senior medical analyst, Dr. Mark Segal,
also author of the book, The Miracles Among Us,
and doctor, good to see you and good morning.
Okay, all right, you're dealing with this stuff all the time.
I don't know how you guys are keeping up with this
because it seems to change every day.
This study, you've looked at it, how do you score it?
Well, I score it high.
The drug is called Rintasirib, Tib,
and it's made by a company called Insilico.
Insilico is a company that simply looks
for AI solutions to create new drugs.
This is something I've been excited about for a long time.
Instead of having to kind of throw things at the wall
and see what works, we use artificial intelligence
to create models of new drugs.
And what this drug does is it's supposed to be used
for idiopathic pulmonary fibrosis, Bill,
which is a terrible, deadly disease
that scars up your lungs, but is rare.
They found in blocking the protein
that leads to that scarring, TNIK,
they literally block scarring around the body.
They stop inflammation.
By modeling, you find that the proteins of the body
aren't wearing down and aging is delayed.
That's really important.
I want the viewers out there to understand how aging occurs.
When you're young, like Bill Hemmer,
or certainly Dana Perrino,
your cells are knocked out of your system
as soon as they wear down.
You got a worn down cell, the body gets rid of it.
When you get older, the body's a little slower.
It says, well, it's still working.
Let's have that cell stay in there.
It's still doing its job, but it's no good for you
because those aging cells lead to inflammation.
They can lead to cancer.
They can lead to heart disease,
so we wanna get them out of there.
This drug leads to those bad cells getting out of the system
and not causing the scarring.
That helps with the lung,
and it looks like it's helping all across the board.
This effect of it, though, has to be further studied, Bill.
It's only been studied in 43 people.
We gotta study this longer,
and we gotta see if it has side effects,
but this is the future of artificial intelligence
and decreasing aging.
43 people, a small sample.
I'm considerably small.
Here's what the head of the company said.
Our AI is tailored to capture the dual-purpose drugs
that are working in aging and disease.
Our core objective is to solve aging
in order to give you time to solve everything else.
That's a heck of a statement there.
They're going after everything.
Give me 100 more years,
I can solve any problem in the world, including Iran.
That's what he's saying, including Iran.
But whether it's lung disease
or another disease that they're looking at,
it seems what he's suggesting is that,
and I'm based on your answer,
is that you can affect aging in other areas.
Now, we'll see whether or not that works.
Absolutely.
As a physician, when you're seeing doctors,
how are you able to keep up with all this AI material?
It's not easy,
because Porter Berry, the head of our website,
told me about this two years ago,
and I've been doing nothing but reading about it ever since,
and studies are burgeoning on this.
We use AI in all kinds of medicine,
radiology, cardiology, patient care,
but it's a co-pilot, Bill.
It's not the pilot.
We need doctors and physician scientists
at the helm looking at it.
It's a tool.
It's a tool to develop new drugs.
Okay, so I'm looking at this thing here, right?
The number of startups, tech giants, and academic labs
working to accelerate drug discovery.
We're about to come into a golden age of medicine,
aren't we?
Yeah, there's no question about that,
because again, as I told you,
what we used to do is we'd look at a computer
and throw different models at the wall.
You're looking at receptors.
How do you get the receptors to accept a new drug?
How do you block a drug?
How do you get a gene to create a different outcome?
How do you block a bad gene?
Well, artificial intelligence tells us
how to do that in record speed.
We can do it in seconds,
and come up with new drugs in a day.
I get it.
Okay, Doc, thanks.
When you get more stuff, come on back, okay?
Good to see you.
There will be more stuff.
Dana's younger than you, Bill.
Dana's younger than you, I'll tell you that.
but we're getting younger by the day.
Haven't you noticed?
Thank you, Doc.
We'll talk soon.
Mark Siegel.
